BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Begagić E, Džidić-Krivić A, Bečulić H, Pugonja R, Ljevaković A, Bašić B, Nuhović A, Milanović E, Hadžić S, Bećirović E, Buljubašić L, Bećirović M, Pojskić M. Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma. World J Clin Oncol 2025; 16(8): 108112 [PMID: 40901320 DOI: 10.5306/wjco.v16.i8.108112]
URL: https://www.wjgnet.com/2218-4333/full/v16/i8/108112.htm
Number Citing Articles
1
Amanda Vergueiro, Aline Menezes, Natália Rocha, Vivaldo Moura-Neto, Adriane Todeschini, Wagner Barbosa Dias. Hyperglycemia promotes O-GlcNAcylation-dependent vulnerability and modulates temozolomide response in glioblastomaBiochemical and Biophysical Research Communications 2026; 828 doi: 10.1016/j.bbrc.2026.154088